Anticancer effect of ursolic acid via mitochondria‑dependent pathways (Review)

  • Authors:
    • Xue‑Min Feng
    • Xiu‑Lan Su
  • View Affiliations

  • Published online on: March 19, 2019     https://doi.org/10.3892/ol.2019.10171
  • Pages: 4761-4767
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ursolic acid is a plant‑derived pentacyclic triterpenoid found in various medicinal herbs and fruits. It has generated clinical interest due to its anti‑inflammatory, antioxidative, antiapoptotic and anticarcinogenic effects. An increasing amount of evidence supports the anticancer effect of ursolic acid in various cancer cells. One of the hallmarks of malignant transformation is metabolic reprogramming that sustains macromolecule synthesis, bioenergetic demand and tumor cell survival. Mitochondria are important regulators of tumorigenes is as well as a major site of the metabolic reactions that facilitate this reprogramming and adaption to cellular and environmental changes. The current review explored the close association between the anticancer effect of ursolic acid and the activation of mitochondrial‑dependent signaling pathways.

References

1 

Warburg O, Wind F and Negelein E: The metabolism of tumors in the body. J Gen Physiol. 8:519–530. 1927. View Article : Google Scholar : PubMed/NCBI

2 

Warburg O: On the origin of cancer cells. Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI

3 

Vander Heiden MG, Cantley LC and Thompson CB: Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science. 324:1029–1033. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004. View Article : Google Scholar : PubMed/NCBI

5 

Vlassenko AG, McConathy J, Couture LE, Su Y, Massoumzadeh P, Leeds HS, Chicoine MR, Tran DD, Huang J, Dahiya S, et al: Aerobic glycolysis as a marker of tumor aggressiveness: Preliminary data in high grade human brain tumors. Dis Markers. 2015:8749042015. View Article : Google Scholar : PubMed/NCBI

6 

Lunt SY and Vander Heiden MG: Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 27:441–464. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Alberts B: Molecular biology of the cell. 4th. New York: Garland Science; 2002

8 

Mathupala SP, Ko YH and Pedersen PL: The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta. 1797:1225–1230. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Wajant H: The Fas signaling pathway: More than a paradigm. Science. 296:1635–1636. 2002. View Article : Google Scholar : PubMed/NCBI

10 

Desagher S and Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Luo X, Budihardjo I, Zou H, Slaughter C and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI

12 

Jiang X and Wang X: Cytochrome C-mediated apoptosis. Annu Rev Biochem. 73:87–106. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Ernster L and Schatz G: Mitochondria: A historical review. J Cell Biol. 91:227s–255s. 1981. View Article : Google Scholar : PubMed/NCBI

14 

Hill RA and Connolly JD: Triterpenoids. Nat Prod Rep. 30:1028–1065. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Jager S, Trojan H, Kopp T, Laszczyk MN and Scheffler A: Pentacyclic triterpene distribution in various plants-rich sources for a new group of multi-potent plant extracts. Molecules. 14:2016–2031. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Szakiel A, Paczkowski C, Pensec F and Bertsch C: Fruit cuticular waxes as a source of biologically active triterpenoids. Phytochem Rev. 11:263–284. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Wozniak L, Skapska S and Marszalek K: Ursolic Acid-A pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules. 20:20614–20641. 2015. View Article : Google Scholar : PubMed/NCBI

18 

Kashyap D, Tuli HS and Sharma AK: Ursolic acid (UA): A metabolite with promising therapeutic potential. Life Sci. 146:201–213. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Santos Rosa C, Garcia Gimenez MD, Saenz Rodriguez MT and De la Puerta Vazquez R: Antihistaminic and antieicosanoid effects of oleanolic and ursolic acid fraction from Helichrysum picardii. Pharmazie. 62:459–462. 2007.PubMed/NCBI

20 

Xu T, Wang X, Zhong B, Nurieva RI, Ding S and Dong C: Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein. J Biol Chem. 286:22707–22710. 2011. View Article : Google Scholar : PubMed/NCBI

21 

Wei ZY, Chi KQ, Wang KS, Wu J, Liu LP and Piao HR: Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents. Bioorg Med Chem Lett. 28:1797–1803. 2018. View Article : Google Scholar : PubMed/NCBI

22 

Lee J, Lee HI, Seo KI, Cho HW, Kim MJ, Park EM and Lee MK: Effects of ursolic acid on glucose metabolism, the polyol pathway and dyslipidemia in non-obese type 2 diabetic mice. Indian J Exp Biol. 52:683–691. 2014.PubMed/NCBI

23 

Poongunran J, Perera HK, Jayasinghe L, Fernando IT, Sivakanesan R, Araya H and Fujimoto Y: Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves. Pharm Biol. 55:206–211. 2017. View Article : Google Scholar : PubMed/NCBI

24 

Lee J, Yee ST, Kim JJ, Choi MS, Kwon EY, Seo KI and Lee MK: Ursolic acid ameliorates thymic atrophy and hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice. Chem Biol Interact. 188:635–642. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Kazmi I, Rahman M, Afzal M, Gupta G, Saleem S, Afzal O, Shaharyar MA, Nautiyal U, Ahmed S and Anwar F: Anti-diabetic potential of ursolic acid stearoyl glucoside: A new triterpenic gycosidic ester from Lantana camara. Fitoterapia. 83:142–146. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Wang YL, Wang ZJ, Shen HL, Yin M and Tang KX: Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit. Eur J Pharm Sci. 50:366–371. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Sundaresan A, Radhiga T and Pugalendi KV: Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice. Eur J Pharmacol. 741:297–303. 2014. View Article : Google Scholar : PubMed/NCBI

28 

Seo DY, Lee SR, Heo JW, No MH, Rhee BD, Ko KS, Kwak HB and Han J: Ursolic acid in health and disease. Korean J Physiol Pharmacol. 22:235–248. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Kunkel SD, Elmore CJ, Bongers KS, Ebert SM, Fox DK, Dyle MC, Bullard SA and Adams CM: Ursolic acid increases skeletal muscle and brown fat and decreases diet-induced obesity, glucose intolerance and fatty liver disease. PLoS One. 7:e393322012. View Article : Google Scholar : PubMed/NCBI

30 

Ma JQ, Ding J, Zhang L and Liu CM: Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway. Clin Res Hepatol Gastroenterol. 39:188–197. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Hollosy F, Idei M, Csorba G, Szabó E, Bökönyi G, Seprödi A, Mészáros G, Szende B and Kéri G: Activation of caspase-3 protease during the process of ursolic acid and its derivative-induced apoptosis. Anticancer Res. 21:3485–3491. 2001.PubMed/NCBI

32 

Wu CC, Huang YF, Hsieh CP, Chueh PJ and Chen YL: Combined use of zoledronic acid augments ursolic Acid-induced apoptosis in human osteosarcoma cells through enhanced oxidative stress and autophagy. Molecules. 21(pii): E16402016. View Article : Google Scholar : PubMed/NCBI

33 

Jiang K, Chi T, Li T, Zheng G, Fan L, Liu Y, Chen X, Chen S, Jia L and Shao JW: Correction: A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: Suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways. Nanoscale. 10:6212–6213. 2018. View Article : Google Scholar : PubMed/NCBI

34 

Zhang H, Li X, Ding J, Xu H, Dai X, Hou Z, Zhang K, Sun K and Sun W: Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). Int J Pharm. 441:261–268. 2013. View Article : Google Scholar : PubMed/NCBI

35 

Harmand PO, Duval R, Liagre B, Jayat-Vignoles C, Beneytout JL, Delage C and Simon A: Ursolic acid induces apoptosis through caspase-3 activation and cell cycle arrest in HaCat cells. Int J Oncol. 23:105–112. 2003.PubMed/NCBI

36 

Cha HJ, Park MT, Chung HY, Kim ND, Sato H, Seiki M and Kim KW: Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells. Oncogene. 16:771–778. 1998. View Article : Google Scholar : PubMed/NCBI

37 

Luo J, Hu YL and Wang H: Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy, and apoptosis and suppressing inflammatory responses via the PI3K/AKT and NF-κB signaling pathways in vitro. Exp Ther Med. 14:3623–3631. 2017. View Article : Google Scholar : PubMed/NCBI

38 

Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, Deregowska A and Wnuk M: Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis. 22:800–815. 2017. View Article : Google Scholar : PubMed/NCBI

39 

Yeh CT, Wu CH and Yen GC: Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol Nutr Food Res. 54:1285–1295. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Subbaramaiah K, Michaluart P, Sporn MB and Dannenberg AJ: Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res. 60:2399–2404. 2000.PubMed/NCBI

41 

Liu L, Zhang J, Li M, Zhang X, Li Z, Wang L, Wu J and Luo C: Inhibition of HepG2 cell proliferation by ursolic acid and polysaccharides via the downregulation of cyclooxygenase-2. Mol Med Rep. 9:2505–2511. 2014. View Article : Google Scholar : PubMed/NCBI

42 

Tian Z, Lin G, Zheng RX, Huang F, Yang MS and Xiao PG: Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolated from Aralia decaisneana. World J Gastroenterol. 12:874–879. 2006. View Article : Google Scholar : PubMed/NCBI

43 

Limami Y, Pinon A, Leger DY, Pinault E, Delage C, Beneytout JL, Simon A and Liagre B: The P2Y2/Src/p38/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells. Biochimie. 94:1754–1763. 2012. View Article : Google Scholar : PubMed/NCBI

44 

Huang HC, Huang CY, Lin-Shiau SY and Lin JK: Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression. Mol Carcinog. 48:517–531. 2009. View Article : Google Scholar : PubMed/NCBI

45 

Wang X, Zhang F, Yang L, Mei Y, Long H, Zhang X, Zhang J, Qimuge S and Su X: Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol. 2011:4193432011. View Article : Google Scholar : PubMed/NCBI

46 

Li R, Wang X, Zhang XH, Chen HH and Liu YD: Ursolic acid promotes apoptosis of SGC-7901 gastric cancer cells through ROCK/PTEN mediated mitochondrial translocation of cofilin-1. Asian Pac J Cancer Prev. 15:9593–9597. 2014. View Article : Google Scholar : PubMed/NCBI

47 

Tang Q, Ji Q, Tang Y, Chen T, Pan G, Hu S, Bao Y, Peng W and Yin P: Mitochondrial translocation of cofilin-1 promotes apoptosis of gastric cancer BGC-823 cells induced by ursolic acid. Tumour Biol. 35:2451–2459. 2014. View Article : Google Scholar : PubMed/NCBI

48 

Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, Xing YY and Xi T: Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anticancer Drugs. 20:249–258. 2009. View Article : Google Scholar : PubMed/NCBI

49 

Wallace DC: A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu Rev Genet. 39:359–407. 2005. View Article : Google Scholar : PubMed/NCBI

50 

Cheng TL, Liao CC, Tsai WH, Lin CC, Yeh CW, Teng CF and Chang WT: Identification and characterization of the mitochondrial targeting sequence and mechanism in human citrate synthase. J Cell Biochem. 107:1002–1015. 2009. View Article : Google Scholar : PubMed/NCBI

51 

Wilson JE: Isozymes of mammalian hexokinase: Structure, subcellular localization and metabolic function. J Exp Biol. 206:2049–2057. 2003. View Article : Google Scholar : PubMed/NCBI

52 

Pedersen PL, Mathupala S, Rempel A, Geschwind JF and Ko YH: Mitochondrial bound type II hexokinase: A key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta. 1555:14–20. 2002. View Article : Google Scholar : PubMed/NCBI

53 

Mathupala SP, Ko YH and Pedersen PL: Hexokinase-2 bound to mitochondria: Cancer's stygian link to the ‘Warburg Effect’ and a pivotal target for effective therapy. Semin Cancer Biol. 19:17–24. 2009. View Article : Google Scholar : PubMed/NCBI

54 

Shoshan-Barmatz V, Zakar M, Rosenthal K and Abu-Hamad S: Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim Biophys Acta. 1787:421–430. 2009. View Article : Google Scholar : PubMed/NCBI

55 

Duval RE, Harmand PO, Jayat-Vignoles C, Cook-Moreau J, Pinon A, Delage C and Simon A: Differential involvement of mitochondria during ursolic acid-induced apoptotic process in HaCaT and M4Beu cells. Oncol Rep. 19:145–149. 2008.PubMed/NCBI

56 

Shanmugam MK, Dai X, Kumar AP, Tan BK, Sethi G and Bishayee A: Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies. Biochem Pharmacol. 85:1579–1587. 2013. View Article : Google Scholar : PubMed/NCBI

57 

Tang X, Gao J, Chen J, Fang F, Wang Y, Dou H, Xu Q and Qian Z: Inhibition by [corrected] ursolic acid of [corrected] calcium-induced mitochondrial permeability transition and release of two proapoptotic proteins. Biochem Biophys Res Commun. 337:320–324. 2005. View Article : Google Scholar : PubMed/NCBI

58 

Shyu MH, Kao TC and Yen GC: Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J Agric Food Chem. 58:6110–6118. 2010. View Article : Google Scholar : PubMed/NCBI

59 

Saraswati S, Agrawal SS and Alhaider AA: Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor. Chem Biol Interact. 206:153–165. 2013. View Article : Google Scholar : PubMed/NCBI

60 

Wang J, Jiang Z, Xiang L, Li Y, Ou M, Yang X, Shao J, Lu Y, Lin L, Chen J, et al: Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis. Sci Rep. 4:50062014. View Article : Google Scholar : PubMed/NCBI

61 

Dong H, Yang X, Xie J, Xiang L, Li Y, Ou M, Chi T, Liu Z, Yu S, Gao Y, et al: UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma. Biochem Pharmacol. 93:151–162. 2015. View Article : Google Scholar : PubMed/NCBI

62 

Wang Y, Branicky R, Noe A and Hekimi S: Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol. 217:1915–1928. 2018. View Article : Google Scholar : PubMed/NCBI

63 

Zorov DB, Juhaszova M and Sollott SJ: Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI

64 

Sies H: Oxidative stress: A concept in redox biology and medicine. Redox Biol. 4:180–183. 2015. View Article : Google Scholar : PubMed/NCBI

65 

Moloney JN and Cotter TG: ROS signalling in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018. View Article : Google Scholar : PubMed/NCBI

66 

Sabharwal SS and Schumacker PT: Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles' heel? Nat Rev Cancer. 14:709–721. 2014. View Article : Google Scholar : PubMed/NCBI

67 

Shadel GS and Horvath TL: Mitochondrial ROS signaling in organismal homeostasis. Cell. 163:560–569. 2015. View Article : Google Scholar : PubMed/NCBI

68 

Tu HY, Huang AM, Wei BL, Gan KH, Hour TC, Yang SC, Pu YS and Lin CN: Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species. Bioorg Med Chem. 17:7265–7274. 2009. View Article : Google Scholar : PubMed/NCBI

69 

Kim KH, Seo HS, Choi HS, Choi I, Shin YC and Ko SG: Induction of apoptotic cell death by ursolic acid through mitochondrial death pathway and extrinsic death receptor pathway in MDA-MB-231 cells. Arch Pharm Res. 34:1363–1372. 2011. View Article : Google Scholar : PubMed/NCBI

70 

Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R and Jacks T: Restoration of p53 function leads to tumour regression in vivo. Nature. 445:661–665. 2007. View Article : Google Scholar : PubMed/NCBI

71 

Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science. 253:49–53. 1991. View Article : Google Scholar : PubMed/NCBI

72 

Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F and Hwang PM: p53 regulates mitochondrial respiration. Science. 312:1650–1653. 2006. View Article : Google Scholar : PubMed/NCBI

73 

Kruse JP and Gu W: p53 aerobics: The major tumor suppressor fuels your workout. Cell Metab. 4:1–3. 2006. View Article : Google Scholar : PubMed/NCBI

74 

Heffernan-Stroud LA, Helke KL, Jenkins RW, De Costa AM, Hannun YA and Obeid LM: Defining a role for sphingosine kinase 1 in p53-dependent tumors. Oncogene. 31:1166–1175. 2012. View Article : Google Scholar : PubMed/NCBI

75 

Nam H and Kim MM: Ursolic acid induces apoptosis of SW480 cells via p53 activation. Food Chem Toxicol. 62:579–583. 2013. View Article : Google Scholar : PubMed/NCBI

76 

Zhang X, Song X, Yin S, Zhao C, Fan L and Hu H: p21 induction plays a dual role in anti-cancer activity of ursolic acid. Exp Biol Med (Maywood). 241:501–508. 2016. View Article : Google Scholar : PubMed/NCBI

77 

Manu KA and Kuttan G: Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells. Int Immunopharmacol. 8:974–981. 2008. View Article : Google Scholar : PubMed/NCBI

78 

Yu YX, Gu ZL, Yin JL, Chou WH, Kwok CY, Qin ZH and Liang ZQ: Ursolic acid induces human hepatoma cell line SMMC-7721 apoptosis via p53-dependent pathway. Chin Med J (Engl). 123:1915–1923. 2010.PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Feng, X., & Feng, X. (2019). Anticancer effect of ursolic acid via mitochondria‑dependent pathways (Review). Oncology Letters, 17, 4761-4767. https://doi.org/10.3892/ol.2019.10171
MLA
Feng, X., Su, X."Anticancer effect of ursolic acid via mitochondria‑dependent pathways (Review)". Oncology Letters 17.6 (2019): 4761-4767.
Chicago
Feng, X., Su, X."Anticancer effect of ursolic acid via mitochondria‑dependent pathways (Review)". Oncology Letters 17, no. 6 (2019): 4761-4767. https://doi.org/10.3892/ol.2019.10171